ASCL1 and neuroblastoma: The relative plasticity of the neurogenic chromatin of NB cells in response to changes in ASCL1 activity opens up the possibility of enhancing endogenous ASCL1 function by dephosphorylation, to promote differentiation for therapeutic benefit in NB.